Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
Maurizio Benucci, Arianna Damiani, María Infantino, Mariangela Manfredi, Valentina Grossi, Barbara Lari, Francesca Li Gobbi, Piercarlo Sarzi‐Puttini
Topics & Concepts
MedicineRheumatoid arthritisRituximabImmunologyVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyAntibodyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and DisordersRheumatoid Arthritis Research and Therapies